- Laboratory animal models are essential tools used in biomedical research, drug development, and toxicity testing, enabling researchers to study human diseases, evaluate potential treatments, and assess the safety of new medical products. These models include a variety of species such as rodents (mice, rats), rabbits, guinea pigs, and non-human primates, each chosen based on the research needs and objectives
- The demand for laboratory animal models is driven by several factors, including the growing need for preclinical testing in drug discovery and development, the rise in chronic diseases such as cancer, neurological disorders, and cardiovascular diseases, and the increasing focus on personalized medicine. Pharmaceutical and biotechnology companies rely heavily on these models for testing the efficacy and safety of new drugs before they are introduced to human clinical trials
- North America is one of the dominant markets for laboratory animal models due to its advanced healthcare infrastructure, high research investment, and well-established pharmaceutical and biotechnology industries. U.S., in particular, remains a leader in drug discovery and development, and its demand for animal models for both regulatory testing and R&D purposes continues to drive market growth. In addition, major research institutes and contract research organizations (CROs) in the region contribute to this demand
- For instance, U.S. is home to numerous large pharmaceutical companies and research organizations, where the use of laboratory animals is integral to the early stages of drug development. These institutions not only utilize animal models extensively but also lead innovations in the field, such as developing genetically modified models for specific diseases
- Asia-Pacific is expected to witness the highest growth in the laboratory animal model market, driven by rapid expansion in pharmaceutical and biotech industries in countries such as China, India, and Japan. The region's growing healthcare and research infrastructure, coupled with the rising need for preclinical testing due to increased R&D activities, are pivotal factors fuelling this market growth
- Globally, laboratory animal models are regarded as an indispensable asset in the preclinical research process. As regulations become more stringent and research efforts become more specialized, the role of laboratory animals in advancing scientific knowledge and facilitating drug approval remains critical. This trend underscores their continued importance in supporting the development of new and more effective treatments across various therapeutic areas
